- World rank, 2022–2025
- #25,573 of 28,054 · #34,221 all time
- Rank in India
- #1,703 of 1,840
- Research works
- 232 ▼ 6% vs 2013–17
- Citations
- 2.3k 10.0 per fractional work
- Top-10% rate
- 7.3% record average 16.5%
- Open access
- 40% world 28%
What is Cipla (India) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Health SciencesDomain | #20,168 of 20,462 | 6.5% | 124 |
Each strip is that field’s whole ranked pool, with the notch where Cipla (India) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 11.4×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 11.4×
- Chemistry 3.8×
- Medicine 2.5×
- Energy 2.0×
- Nursing 1.9×
- Veterinary 1.8×
- Biochemistry, Genetics and Molecular Biology 1.6×
- Health Professions 1.3×
- Neuroscience 1.1×
- Agricultural and Biological Sciences 1.1×
- Mathematics 1.1×
- Materials Science 1.0×
- Decision Sciences 0.8×
- Immunology and Microbiology 0.6×
- Business, Management and Accounting 0.5×
- Engineering 0.5×
- Environmental Science 0.4×
- Economics, Econometrics and Finance 0.3×
- Computer Science 0.2×
- Social Sciences 0.1×
Who are the top researchers at Cipla (India)?
Ranked on the composite score, Jaideep Gogtay and Senthilnathan Mohanasundaram lead among researchers whose main affiliation is Cipla (India).
- 1 Jaideep Gogtay India · #1,583,746 worldwide 0 citations · 21 works
- 2 Senthilnathan Mohanasundaram India · #1,631,208 worldwide 2 citations · 15 works
Which keywords describe research at Cipla (India)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Inflammation, Genetics, Nanoparticles, Treatment, Inhaler Devices, Pulmonary Drug Delivery, Asthma and Epidemiology.
- Pulmonary Hypertension
- Mutation
- Crystallization
- Type 2 Diabetes
- Near-Infrared Spectroscopy
- Drug Delivery
- Quality Assessment
- Seizures
- Drug Resistance
- Insulin Therapy
- Heart Failure
- spirometry
- Respiratory
- Principal Component Analysis
- Cardiovascular Disease
- Eosinophils
- Asthma
- Inhaler Devices
- Genetics
- Epidemiology
- Inflammation
- Nanoparticles
- Treatment
- Pulmonary Drug Delivery
- Allergic Diseases
- Diagnosis
- Global Burden
- Management
- COPD
- Biomedical Applications
- Glycemic Control
- Clinical Guidelines
- Epilepsy
- Cancer Therapy
- Crystal Engineering
- Multivariate Calibration
- Cardiovascular Outcomes
- Chronic Disease Management
- Nucleation
- Method Validation
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation8▲ 6.0×15 topics
- Epidemiology7▲ 2.7×19 topics
- Nanoparticles6▲ 7.5×7 topics
- Genetics6▲ 13×3 topics
- Treatment6▲ 6.8×7 topics
- Inhaler Devices5▲ 277×1 topic
- Pulmonary Drug Delivery5▲ 277×1 topic
- Asthma4▲ 68×2 topics
- Allergic Diseases4▲ 106×1 topic
- Eosinophils4▲ 106×1 topic
- Diagnosis3▲ 5.0×5 topics
- Cardiovascular Disease3▲ 3.8×9 topics
- Global Burden3▲ 7.7×3 topics
- Principal Component Analysis2▲ 26×4 topics
- Management2▲ 4.5×3 topics
- Respiratory2▲ 36×2 topics
- COPD2▲ 51×1 topic
- spirometry2▲ 51×1 topic
- Biomedical Applications2▲ 2.7×8 topics
- Heart Failure2▲ 7.3×6 topics
- Glycemic Control2▲ 20×2 topics
- Insulin Therapy2▲ 26×2 topics
- Clinical Guidelines2▲ 9.9×3 topics
- Drug Resistance2▲ 11×2 topics
- Epilepsy2▲ 27×1 topic
- Seizures2▲ 48×1 topic
- Cancer Therapy2▲ 4.5×9 topics
- Quality Assessment2▲ 13×2 topics
- Crystal Engineering2▲ 21×3 topics
- Drug Delivery2▲ 4.2×5 topics
- Multivariate Calibration2▲ 32×1 topic
- Near-Infrared Spectroscopy2▲ 24×1 topic
- Cardiovascular Outcomes1▲ 37×1 topic
- Type 2 Diabetes1▲ 8.9×1 topic
- Chronic Disease Management1▲ 10×2 topics
- Crystallization1▲ 36×1 topic
- Nucleation1▲ 112×1 topic
- Mutation1▲ 9.0×3 topics
- Method Validation1▲ 29×2 topics
- Pulmonary Hypertension1▲ 11×3 topics
Which research topics does Cipla (India) publish most on?
By volume in 2022–2025: Inhalation and Respiratory Drug Delivery, Asthma and respiratory diseases, Chronic Obstructive Pulmonary Disease (COPD) Research and Epilepsy research and treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Inhalation and Respiratory Drug Delivery Pulmonary and Respiratory Medicine 5 works
- 2 Asthma and respiratory diseases Physiology 4 works
- 3 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 2 works
- 4 Epilepsy research and treatment Psychiatry and Mental health 2 works
- 5 Spectroscopy and Chemometric Analyses Analytical Chemistry 2 works
- 6 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 1 works
- 7 Crystallization and Solubility Studies Materials Chemistry 1 works
- 8 Mobile Health and mHealth Applications General Health Professions 1 works
- 9 Global Energy and Sustainability Research Renewable Energy, Sustainability and the Environment 1 works
- 10 Advanced Drug Delivery Systems Pharmaceutical Science 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Cipla (India)'s research output changed?
Output in 2018–2022 was 6% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Mumbai
- Indian Institute of Technology Bombay
- Bhabha Atomic Research Centre
- Tata Institute of Fundamental Research
- University of Mumbai
- Institute of Chemical Technology
- Homi Bhabha National Institute
- Tata Memorial Hospital
- Narsee Monjee Institute of Management Studies
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.